Biocon Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is TACROLIMUS GRANULES 20% W/W, with a corresponding US DMF Number 29786.
Remarkably, this DMF maintains an Active status since its submission on September 24, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 18, 2016, and payment made on September 22, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II